A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alpha(?) integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer

Author:

Heidenreich, A.; Rawal, S. K.; Szkarlat, K.; Bogdanova, N.; Dirix, L.; Stenzl, A.; Welslau, M.; Wang, G.; Dawkins, F.; de Boer, C. J.; Schrijvers, D.

Tübinger Autor(en):

Published in:

Annals of Oncology (2013), Bd. 24, H. 2, S. 329-336

Verlagsangabe:

Oxford Univ Press

Language:

English

Full text:

ISSN:

0923-7534

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)